Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials

✍ Scribed by Kavanaugh, Arthur (author);Ritchlin, Christopher (author);Rahman, Proton (author);Puig, Lluis (author);Gottlieb, Alice B. (author);Li, Shu (author);Wang, Yuhua (author);Noonan, Lenore (author);Brodmerkel, Carrie (author);Song, Michael (author);Mendelsohn, Alan M. (author);McInnes, Iain B. (author)

• Book ID: 126463926
• Publisher: BMJ Publishing Group
• Year: 2014
• Tongue: English
• Weight: 984 KB
• Volume: 73
• Category: Article
• ISSN: 0003-4967
• DOI: 10.1136/annrheumdis-2013-204741